Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Asclera. Always confirm against the full prescribing information.
14 interactions
Certolizumab pegol
The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Polidocanol.
Level 2 evidence
Damoctocog alfa pegol
The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Polidocanol.
Level 2 evidence
Elapegademase
The therapeutic efficacy of Elapegademase can be decreased when used in combination with Polidocanol.
Level 2 evidence
Methoxy polyethylene glycol-epoetin beta
The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Polidocanol.
Level 2 evidence
Pegaspargase
The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegaspargase.
Level 2 evidence
Pegfilgrastim
The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegfilgrastim.
Level 2 evidence
Peginterferon alfa-2a
The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2a.
Level 2 evidence
Peginterferon alfa-2b
The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2b.
Level 2 evidence
Peginterferon beta-1a
The therapeutic efficacy of Peginterferon beta-1a can be decreased when used in combination with Polidocanol.
Level 2 evidence
Pegloticase
The therapeutic efficacy of Pegloticase can be decreased when used in combination with Polidocanol.
Level 2 evidence
Pegvaliase
The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Polidocanol.
Level 2 evidence
Pegvisomant
The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegvisomant.
Asclera (Polidocanol) has 14 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Asclera (Polidocanol) has 0 major, 0 moderate, and 14 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Asclera. Always confirm against the full prescribing information.